The strategic plan of Tufts Medical Center identified Cancer as a primary target. Responding to this plan, the Board of Tufts Medical Center established the Molecular Oncology Research Institute (MORI). Philip N. Tsichlis MD, was appointed as its Executive Director on September 1, 2002.
MORI, a core component of the Cancer Center at Tufts Medical Center, has 17 faculty members currently and occupies a space of more than 31,000 square feet in the 75 Kneeland Street research building. Its mission is to explore the molecular mechanisms of neoplastic transformation and to promote the translation of basic research findings into the clinic. To achieve this goal, MORI scientists carry out research that spans the spectrum from gene discovery to target validation for drug development.
|
|
Upcoming Seminars
Seminar
“Lentiviral
Transgenesis:
RNAi-mediated
downregulation of gene expression in mouse models”
Kibibi
Rwayitare, Microinjectionist
Tuesday,
May 13, 2008
Behrakis
Auditorium, Jaharis Building
[ Click Here for Additional Information ]
|
